Related Experiment Video

Updated: Apr 17, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.9K

Intracellular signals of lung cancer cells as possible therapeutic targets

Kiyomichi Tanaka1, Keiki Kumano1, Hiroo Ueno1

  • 1Department of Stem Cell Pathology, Kansai Medical University, Hirakata, Japan.

Cancer Science
|February 25, 2015
PubMed

Insights

Targeted therapies improve lung cancer treatment, but many oncogenes remain untreated. Research into lung cancer stem cells and causal genes is crucial for developing new, effective therapies and overcoming drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Lung cancer treatment has advanced with molecularly targeted therapies showing significant success.
  • However, numerous oncogenes driving lung cancer are not targeted by current therapies.
  • Lung cancer is a heterogeneous disease requiring individualized treatment strategies.

Purpose of the Study:

  • To review major causal genes and intracellular signaling pathways in lung cancer.
  • To explore the role of lung epithelial stem cells and cancer stem cells in lung cancer development.
  • To discuss the potential for developing novel molecularly targeted therapies based on stem cell research.

Main Methods:

  • Literature review of studies on lung cancer causal genes and signaling pathways.
  • Analysis of research on lung epithelial stem cells and cancer stem cell origins.
  • Examination of mechanisms underlying drug resistance in lung cancer.

Main Results:

  • Identified key oncogenes and signaling pathways implicated in lung cancer.
  • Highlighted the importance of understanding lung cancer stem cells and their origins.
  • Discussed the challenge of acquired drug resistance in targeted therapy.

Conclusions:

  • Developing individualized therapies targeting specific causal genes is essential for lung cancer treatment.
  • Further research into lung cancer stem cells and their signaling pathways is critical for novel therapeutic strategies.
  • Addressing drug resistance mechanisms is key to improving long-term treatment outcomes.
Keywords:
Lung cancerlung cancer stem cellslung stem cellsmolecularly targeted therapysurvival signals

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

961

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

37.3K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
55.6K